Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892494442> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2892494442 abstract "286 Background: Over 30 million adults in the U.S. have diabetes (DM), 7 million of which are undiagnosed. Patients with DM undergoing cancer treatment have been shown to have increased rates of complications and shorter survival. Patients commonly receive glucocorticoids (GC) with chemotherapy (CT), which may lead to hyperglycemia. Data regarding the optimal approach to screening and outpatient management of patients receiving CT with GC is lacking. We sought to describe the incidence of diabetes, hyperglycemia, and implemented a quality improvement project to refer eligible patients for DM education and management. Methods: We identified 100 patients with cancer starting a new CT regimen including GC. We obtained screening labs, baseline random glucose, HbA1c, and body-mass index (BMI) for each patient prior to starting CT. Follow-up glucose values were obtained with each cycle; patients were followed for a maximum of 3 cycles of CT. Patients with a baseline HbA1c ≥6.5%, a baseline random glucose ≥200mg/dL, follow up glucose ≥200mg/dL, and/or a prior DM diagnosis were referred to the Park Nicollet International Diabetes Center (IDC) to receive DM education and management. Results: 23% of patients had known DM and 17% had known prediabetes prior to their first CT cycle. Baseline HbA1c values were ≥6.5% in 18% of patients, 5.7-6.4% in 39% of patients, and ≤5.6% in 43% of patients. Among the 18 patients with baseline HbA1c ≥6.5%, 13 had known DM, 1 had known prediabetes, and 4 were undiagnosed. 67% of our study population had a baseline BMI ≥25. 12 patients had at least one follow up glucose ≥200mg/dL. Of those 12, 92% had known DM, 67% had a baseline HbA1c ≥6.5%, and 75% had a baseline BMI ≥25. 29 patients met IDC referral criteria, however, only 14 were ultimately seen in consultation. Conclusions: Adding HbA1c to baseline laboratory evaluations identified individuals with undiagnosed DM. DM history, baseline HbA1c, and BMI were associated with hyperglycemic events among patients receiving CT with GC. Future studies are needed to evaluate the impact of DM education and management on both glycemic control and clinical outcomes." @default.
- W2892494442 created "2018-10-05" @default.
- W2892494442 creator A5007119846 @default.
- W2892494442 creator A5032153972 @default.
- W2892494442 creator A5071370716 @default.
- W2892494442 creator A5087805885 @default.
- W2892494442 creator A5089908393 @default.
- W2892494442 date "2018-10-20" @default.
- W2892494442 modified "2023-10-16" @default.
- W2892494442 title "Incidence of diabetes and hyperglycemia among patients receiving glucocorticoids with chemotherapy." @default.
- W2892494442 doi "https://doi.org/10.1200/jco.2018.36.30_suppl.286" @default.
- W2892494442 hasPublicationYear "2018" @default.
- W2892494442 type Work @default.
- W2892494442 sameAs 2892494442 @default.
- W2892494442 citedByCount "0" @default.
- W2892494442 crossrefType "journal-article" @default.
- W2892494442 hasAuthorship W2892494442A5007119846 @default.
- W2892494442 hasAuthorship W2892494442A5032153972 @default.
- W2892494442 hasAuthorship W2892494442A5071370716 @default.
- W2892494442 hasAuthorship W2892494442A5087805885 @default.
- W2892494442 hasAuthorship W2892494442A5089908393 @default.
- W2892494442 hasConcept C120665830 @default.
- W2892494442 hasConcept C121332964 @default.
- W2892494442 hasConcept C121608353 @default.
- W2892494442 hasConcept C126322002 @default.
- W2892494442 hasConcept C134018914 @default.
- W2892494442 hasConcept C2776694085 @default.
- W2892494442 hasConcept C2777180221 @default.
- W2892494442 hasConcept C2779668308 @default.
- W2892494442 hasConcept C2780221984 @default.
- W2892494442 hasConcept C2781413609 @default.
- W2892494442 hasConcept C2908647359 @default.
- W2892494442 hasConcept C555293320 @default.
- W2892494442 hasConcept C61511704 @default.
- W2892494442 hasConcept C71924100 @default.
- W2892494442 hasConcept C99454951 @default.
- W2892494442 hasConceptScore W2892494442C120665830 @default.
- W2892494442 hasConceptScore W2892494442C121332964 @default.
- W2892494442 hasConceptScore W2892494442C121608353 @default.
- W2892494442 hasConceptScore W2892494442C126322002 @default.
- W2892494442 hasConceptScore W2892494442C134018914 @default.
- W2892494442 hasConceptScore W2892494442C2776694085 @default.
- W2892494442 hasConceptScore W2892494442C2777180221 @default.
- W2892494442 hasConceptScore W2892494442C2779668308 @default.
- W2892494442 hasConceptScore W2892494442C2780221984 @default.
- W2892494442 hasConceptScore W2892494442C2781413609 @default.
- W2892494442 hasConceptScore W2892494442C2908647359 @default.
- W2892494442 hasConceptScore W2892494442C555293320 @default.
- W2892494442 hasConceptScore W2892494442C61511704 @default.
- W2892494442 hasConceptScore W2892494442C71924100 @default.
- W2892494442 hasConceptScore W2892494442C99454951 @default.
- W2892494442 hasLocation W28924944421 @default.
- W2892494442 hasOpenAccess W2892494442 @default.
- W2892494442 hasPrimaryLocation W28924944421 @default.
- W2892494442 hasRelatedWork W1975942988 @default.
- W2892494442 hasRelatedWork W2017539547 @default.
- W2892494442 hasRelatedWork W2047553073 @default.
- W2892494442 hasRelatedWork W2090844872 @default.
- W2892494442 hasRelatedWork W2093255976 @default.
- W2892494442 hasRelatedWork W2263796076 @default.
- W2892494442 hasRelatedWork W2296094089 @default.
- W2892494442 hasRelatedWork W2367206690 @default.
- W2892494442 hasRelatedWork W2368107378 @default.
- W2892494442 hasRelatedWork W2371855065 @default.
- W2892494442 isParatext "false" @default.
- W2892494442 isRetracted "false" @default.
- W2892494442 magId "2892494442" @default.
- W2892494442 workType "article" @default.